Condition: Tumor · Sponsor: General University Hospital, Prague
Tru-cut biopsy (TCB) is a minimally invasive method to get an adequate sample from the lesion in order to tailor the appropriate management avoiding unnecessary surgery. The aim of our trial is to evaluate the adequacy, accuracy and safety of the method related to the final histology as reference standard.
This description comes directly from the study's public registry record.
Renata Poncová, MD. · +420731573737 · poncova.renata@gmail.com
Filip Frühauf, MD. · filip.fruehauf@vfn.cz
Always discuss trial participation with your own doctor first.
| Department of Gynecology, Obstetrics and Neonatology of First Faculty of Medicine and General University Hospital in Prague | Prague, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06816160